SOD3 and Alzheimer disease: SOD3-MSCs might lead to successful outcomes in clinical trials since SOD3-introduced MSCs possess potent immunomodulatory abilities required for AD alleviation, as compared to naïve MSCs, and SOD3 enzyme is expected to prolong the survival of MSCs after transplantation, by attenuating damage from ROS in the lesion.